ivosidinib,azacitidine
servier
['leukemia', 'myeloid', 'agile', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'servier']
we re sharing updated efficacy and safety data from the agile study in patients with newly diagnosed acute myeloid leukemia (aml) at the annual meeting. these data underscore the importance of testing for an idh1 mutation in aml. learn more: 
Servier Pharmaceuticals is a U.S. subsidiary of Servier with a focus on oncology treatment and care. See our community guidelines here: https://t.co/tHNeTw4iGH